TickerFacts.

Biodesix Inc (BDSX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$22.20M
Year ended 2025-12-31
-$15.03M
Trailing 12 months to 2026-06-30
2019-12-31: -$23.95M2020-12-31: -$20.03M2021-12-31: -$37.76M2022-12-31: -$46.99M2023-12-31: -$38.01M2024-12-31: -$28.73M2025-12-31: -$22.20M-$22.20M
2019-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$22.20Mn/m2026-02-26, From 2025-01-01
2024-12-31-$28.73Mn/m2026-02-26, From 2024-01-01
2023-12-31-$38.01Mn/m2025-03-03, From 2023-01-01
2022-12-31-$46.99Mn/m2024-03-01, From 2022-01-01
2021-12-31-$37.76Mn/m2023-03-06, From 2021-01-01
2020-12-31-$20.03Mn/m2022-03-14, From 2020-01-01
2019-12-31-$23.95Mn/a2021-03-16, From 2019-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Biodesix Inc (BDSX)2025-12-31-$22.20Mn/m
Personalis, Inc. (PSNL)2025-12-31-$78.01Mn/m
Exagen Inc. (XGN)2025-12-31-$11.97Mn/m
American Shared Hospital Services (AMS)2025-12-31$2.13M-36.9%
BillionToOne, Inc. (BLLN)2025-12-31$22.92Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$66.97Mn/m
Castle Biosciences Inc (CSTL)2025-12-31-$2.04Mn/m
CareDx, Inc. (CDNA)2025-12-31-$15.76Mn/m
Veracyte, Inc. (VCYT)2025-12-31$79.19M+100.0%

Compare BDSX, PSNL, XGN, AMS side by side · Screen every company in Services-Medical Laboratories ↗